不確定

這篇應該是比較權威的雙盲臨試報告

https://www.nejm.org/doi/full/10.1056/nejmoa2115869

CONCLUSIONS

Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to progression of Covid-19 or of prolonged emergency department observation among outpatients with an early diagnosis of Covid-19. (Funded by FastGrants and the Rainwater Charitable Foundation; TOGETHER ClinicalTrials.gov number, NCT04727424）

 

 

這篇“綜述”說防重症

https://journals.lww.com/americantherapeutics/fulltext/2021/08000/ivermectin_for_prevention_and_treatment_of.7.aspx

Conclusions: 

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

 

所有跟帖： 

• 謝謝！ -魔羯鼠養貓- ♀ (0 bytes) () 12/15/2022 postreply 07:56:16